Janssen files MS pill, ahead of FDA decision on BMS' rival

Janssen has filed its ponesimod pill with the FDA for treatment of adults with relapsing multiple sclerosis, days before the regulator is due to make a decision on a rival from Bristol-Myer

Roche begins phase 3 trial of Actemra in COVID-19 pneumonia

Roche is to begin a phase 3 trial of its Actemra/RoActemra as a treatment for patients hospitalised with severe COVID-19 pneumonia, following independent research in China suggesting it may

Duo of UK firms announce coronavirus therapy trials

Two UK firms have announced plans to begin trials of therapies to tackle the coronavirus outbreak.

FDA guides on running clinical trials during coronavirus out...

The FDA has responded to concerns about the impact on clinical trials of the novel coronavirus with guidance on how to modify trial designs to mitigate the impact of the COVID-19 crisis.

Merck’s chronic cough drug gefapixant clears phase 3 test

BioNTech shares pop after coronavirus vaccine deal with Pfiz...

As the coronavirus pandemic spreads across the world and the pressure on health system and economies mounts, Pfizer and BioNTech have agreed to jointly develop a vaccine to prevent the infe